The research reveals that the LY6E protein impairs the coronavirus’ ability to initiate infection, which could lead to treatments for the illness.
Up-and-Coming Diagnostic Test Developers Emerge as Consolidation Thins the Field.
10 privately-held diagnostics developers primarily focused on liquid biopsy tests, ranked by total money raised from venture capital firms.
The company has begun marketing to consumers its PRS-based preconception test expected to be available later this year.
ACE inhibitors and Angiotensin Receptor Blockers May Increase Mortality Rate In Elderly COVID-19 Patients
These highly prescribed medications change cell surface protein expression, which is particularly problematic in cells in the respiratory system—tissue that is vulnerable to targeting and attack by the COVID-19 virus.
A specialized hydrogel can not only encapsulate and protect mRNA cancer vaccines from being broken down in the body, but can also target lymph nodes to activate immune cells, shows early stage research.
These ten governments have committed funding for projects that will sequence a minimum of 100,000 citizens to spur genomic medicine
If companion diagnostics (CDx) were people, they would be old enough to drink. The first CDx won FDA approval in 1998, when Dako Denmark...
The results demonstrated that patients who were taking drugs to speed up the breakdown of fats in their lungs were recovering from lung infections caused by COVID-19 in a matter of days—with no mortality among these patients.
This year’s list of innovative companies have all found, or developed, technology solutions that have allowed them to become innovators in their niche.